Compare · ACN vs FLAC
ACN vs FLAC
Side-by-side comparison of Accenture plc (ACN) and Frazier Lifesciences Acquisition Corporation (FLAC): market cap, price performance, sector, and recent activity on the wire.
Summary
- ACN operates in Consumer Discretionary, while FLAC operates in Finance - the two are in different parts of the market.
- ACN carries a market cap of $167.14B.
- ACN has hit the wire 33 times in the past 4 weeks while FLAC has been quiet.
- ACN has more recent analyst coverage (25 ratings vs 0 for FLAC).
- Company
- Accenture plc
- Frazier Lifesciences Acquisition Corporation
- Price
- -
- -
- Market cap
- $167.14B
- -
- 1M return
- +18.81%
- -
- 1Y return
- +2.90%
- -
- Industry
- Business Services
- Business Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2001
- 2021
- News (4w)
- 33
- 0
- Recent ratings
- 25
- 0
Accenture plc
Accenture plc, a professional services company, provides strategy and consulting, interactive, and technology and operations services worldwide. The company also provides outsourcing services. It serves communications, media, high tech, software, and platform companies; banking, capital market, and insurance industries; and consumer goods, retail, travel services, industrial, and life science industries, as well as clients in health, public service, chemicals and natural resources, energy, and utility sectors. Accenture plc has alliance relationships with Adobe, Alibaba, Amazon Web Services, Blue Yonder, Cisco, Dell, Google, HPE, IBM RedHat, Microsoft, Oracle, Pegasystems, Salesforce, SAP, ServiceNow, VMWare, Workday, Massachusetts Institute of Technology, Institut Polytechnique de Paris, CNH Industrial, and Reactive Technologies. It has an agreement with Duke Energy Corporation for the development of a technology platform designed to measure actual baseline methane emissions from natural gas distribution systems. The company was incorporated in 2009 and is based in Dublin, Ireland.
Frazier Lifesciences Acquisition Corporation
Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.
Latest ACN
- SEC Form SCHEDULE 13G filed by Accenture plc
- Strategy/Reinvention Svcs Ofcr Sharma Manish was granted 68 units of Class A ordinary shares, increasing direct ownership by 0.64% to 10,626 units (SEC Form 4)
- Chief Leadership & HR Officer Clifford Katherine Lee was granted 65 units of Class A ordinary shares, increasing direct ownership by 0.93% to 7,058 units (SEC Form 4)
- General Counsel, Corp Sec, CRO Unruch Joel was granted 102 units of Class A ordinary shares, increasing direct ownership by 0.45% to 22,993 units (SEC Form 4)
- CEO-Americas Walsh John F was granted 103 units of Class A ordinary shares, increasing direct ownership by 0.33% to 31,523 units (SEC Form 4)
- Chair and CEO Sweet Julie Spellman was granted 144 units of Class A ordinary shares, increasing direct ownership by 0.29% to 49,054 units (SEC Form 4)
- Chief Operating Officer Hogan Catherine Kiernan was granted 80 units of Class A ordinary shares, increasing direct ownership by 0.62% to 13,084 units (SEC Form 4)
- Chief Financial Officer Park Angie Y was granted 102 units of Class A ordinary shares, increasing direct ownership by 0.72% to 14,327 units (SEC Form 4)
- Chief Accounting Officer Burgum Melissa A was granted 75 units of Class A ordinary shares, increasing direct ownership by 0.77% to 9,836 units (SEC Form 4)
- Ontario's Workplace Safety and Insurance Board Cuts Employer Registration Time from Days to Minutes with Guidewire
Latest FLAC
- SEC Form SC 13G/A filed by Frazier Lifesciences Acquisition Corporation (Amendment)
- SEC Form 15-12G filed by Frazier Lifesciences Acquisition Corporation
- SEC Form SC 13G/A filed by Frazier Lifesciences Acquisition Corporation (Amendment)
- SEC Form SC 13D/A filed by Frazier Lifesciences Acquisition Corporation (Amendment)
- SEC Form 4 filed by Viking Global Investors Lp
- Frazier Lifesciences Acquisition Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 4 filed by Topper David Joseph
- SEC Form 4 filed by Bigham Michael
- SEC Form 4 filed by Polu Krishna R
- SEC Form 4 filed by Baltera Robert Jr.